RECOMBINANT HUMAN FACTOR-XA(ASN322ALA419) IS A POTENT ANTITHROMBOTIC AGENT IN A RABBIT MODEL OF VENOUS THROMBOSIS

被引：0
|
作者：
HOLLENBACH, S [1 ]
NEEDHAM, K [1 ]
FREY, L [1 ]
LIN, PH [1 ]
HANCOCK, TE [1 ]
SINHA, U [1 ]
WOLF, DL [1 ]
机构：
[1] COR THERAPEUT INC,S SAN FRANCISCO,CA
来源：
CIRCULATION | 1992年 / 86卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：410 / 410
页数：1
相关论文
共 34 条
  • [21] The characterization of selective Factor-Xa inhibitor; KFA-1411 in venous thrombosis and bleeding model during continuous infusion in rats.
    Hara, K
    Honma, T
    Nagano, R
    Matsuzawa, A
    Akahane, S
    Kitazawa, M
    BLOOD, 1998, 92 (10) : 119B - 119B
  • [22] Recombinant Human Tissue Factor Pathway Inhibitor Prevents Thrombosis in a Venous Tuck Model
    Ezzat, Waleed H.
    Dahl, John P.
    Luginbuhl, Adam
    Gordin, Eli
    Krein, Howard
    Heffelfinger, Ryan N.
    LARYNGOSCOPE, 2010, 120 (11): : 2172 - 2176
  • [23] Antithrombotic effect of YM466, a synthesized factor Xa inhibitor, in arterio-venous shunt thrombosis model in squirrel monkeys
    Iwatsuki, Y
    Kaku, S
    Sakai-Moritani, Y
    Taniuchi, Y
    Mano, Y
    Usui, T
    Iizumi, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 76P - 76P
  • [24] ENHANCEMENT OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR-INDUCED REPERFUSION BY RECOMBINANT TICK ANTICOAGULANT PEPTIDE, A SELECTIVE FACTOR-XA INHIBITOR, IN A CANINE MODEL OF FEMORAL ARTERIAL THROMBOSIS
    MELLOTT, MJ
    STRANIERI, MT
    SITKO, GR
    STABILITO, II
    LYNCH, JJ
    VLASUK, GP
    FIBRINOLYSIS, 1993, 7 (03) : 195 - 202
  • [25] Long-term antithrombotic effects of human recombinant, active site-blocked factor VII in a chronic rabbit model of intravascular thrombosis.
    Golino, P
    Cirillo, P
    D'Andrea, D
    Ragni, M
    Calabr, P
    Ravera, M
    Tommasini, P
    Ezban, M
    Chiariello, M
    CIRCULATION, 1998, 98 (17) : 727 - 727
  • [26] Antithrombotic properties of DU-176b, a novel, potent and orally active direct factor Xa inhibitor in rat models of arterial and venous thrombosis: Comparison with fondaparinux, an antithrombin dependent factor Xa inhibitor.
    Fukuda, T
    Matsumoto, C
    Honda, Y
    Sugiyama, N
    Morishima, Y
    Shibano, T
    BLOOD, 2004, 104 (11) : 513A - 513A
  • [27] Antithrombotic effects of YM466, a synthesized direct inhibitor of factor Xa, in an arterio-venous shunt thrombosis model in squirrel monkeys
    Iwatsuki, Y
    Kaku, S
    Moritani, Y
    Taniuchi, Y
    Hirayama, F
    Koshio, H
    Matsumoto, Y
    Mano, Y
    Kawasaki, T
    DRUG DEVELOPMENT RESEARCH, 2003, 58 (02) : 190 - 195
  • [28] Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis
    Wang, Xinkang
    Li, Qiu
    Du, Fuyong
    Shukla, Neetu
    Nawrocki, Andrea R.
    Chintala, Madhu
    TH OPEN, 2023, 07 (02) : e97 - e104
  • [29] Dose-dependent Antithrombotic effects of apixaban, an oral direct factor Xa inhibitor, in prevention and treatment of thrombosis in rabbit models of arteriovenous-shunt and venous thrombosis at doses that preserve hemostasis
    Wong, Pancras C.
    Crain, Earl J.
    Pinto, Donald
    Watson, Carol A.
    BLOOD, 2007, 110 (11) : 283A - 283A
  • [30] ACCELERATION OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR INDUCED REPERFUSION AND PREVENTION OF REOCCLUSION BY RECOMBINANT ANTISTASIN, A SELECTIVE FACTOR-XA INHIBITOR, IN A CANINE MODEL OF FEMORAL ARTERIAL THROMBOSIS
    MELLOTT, MJ
    HOLAHAN, MA
    LYNCH, JJ
    VLASUK, GP
    DUNWIDDIE, CT
    CIRCULATION RESEARCH, 1992, 70 (06) : 1152 - 1160
1234